0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Galangin Improved Non-Alcoholic Fatty Liver Disease in Mice by Promoting Autophagy [Corrigendum]

      Drug Design, Development and Therapy

      Dove

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Zhang X, Deng Y, Xiang J, et al. Drug Des Devel Ther. 2020;14:3393–3405. The authors have advised that the Acknowledgments statement before the Disclosure section was missed on page 3404 of the published paper. The Acknowledgments statement should read as follows: Acknowledgments This work was supported by Youth Program of National Natural Science Foundation of China (21708050), Hunan Provincial Health Committee’s General Subsidy Project (20200100), General Program of National Natural Science Foundation of China (8187032317) and In-hospital Youth Fund of Xiangya Hospital of Central South University (2015Q03).

          Related collections

          Author and article information

          Journal
          Drug Des Devel Ther
          Drug Des Devel Ther
          dddt
          dddt
          Drug Design, Development and Therapy
          Dove
          1177-8881
          20 January 2021
          2021
          20 January 2021
          : 15
          : 231
          Article
          301054
          10.2147/DDDT.S301054
          7829596
          33505157
          © 2021 Zhang et al.

          This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

          Page count
          Figures: 0, Pages: 1
          Categories
          Corrigendum

          Pharmacology & Pharmaceutical medicine

          Comments

          Comment on this article